Bone Growth Stimulator Market size is estimated to cross USD 5 Billion by the end of 2033, growing at a CAGR of 7% during the forecast period, i.e., 2023-2033. In the year 2022, the industry size of bone growth stimulator was USD 2 Billion. The growth of the market is primarily ascribed to the growing incidences of bone fractures throughout the world. Incidents such as falls, auto accidents, or sports injuries frequently result in fractures. However, certain health issues and repeated motions such as jumping, or exercising might also increase the likelihood of getting a specific type of fracture. For instance, it was observed in a study, worldwide, approximately 180 million (94% UI 161-197) new bone fractures were reported in 2019 (a boost of 34 % since 1990).
A bone growth stimulator is an electrical stimulation treatment used to enhance bone healing in complicated fractures. It is an alternative therapy that is mostly suggested by surgeons to speed up the healing process of fractures. The bone growth stimulator is also known as an osteogenesis stimulator device and delivers a pain-free ultrasound. The notably increasing cases of road accidents and trauma that lead to severe bone fractures are boosting the growth of the global bone growth stimulator market over the forecast period. Road accidents can cause many physical, emotional, and financial predicaments for the people affected. They are often caused owing to reasons such as not following traffic rules, driving in an inebriated state, and even poor road conditions cause many accidents every year. According to World Health Organization (WHO) data, globally, around 1.3 million people die in road accidents each year.
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
7% |
|
Base Year Market Size (2022) |
USD 2 Billion |
|
Forecast Year Market Size (2033) |
USD 5 Billion |
|
Regional Scope |
|
Application (Delayed Union & Non-union Bone Fractures, Spinal Fusion Surgeries, Oral & Maxillofacial Surgeries)
The global bone growth stimulator market is segmented and analyzed for demand and supply by application into delayed union & non-union bone fractures, spinal fusion surgeries, and oral & maxillofacial surgeries. Amongst these segments, the spinal fusion surgeries segment is projected to garner the largest market share over the forecast period. It is backed by the staggering count of patient pools undergoing spinal fusion surgeries throughout the world.Spinal fusion is a surgical procedure to link disconnected spinal bones back together again. A substance similar to bone is inserted between the bones during the process. The bones may then be held together using plates, orthopedic braces, screws, or rods made of inert materials. Eventually, the bones fuse and become one bone to recover. For instance, every year approximately 1.70 million instrumented spinal fusion surgeries are performed in the United States.
End-user (Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Home Care)
The global bone growth stimulator market is also segmented and analyzed for demand and supply by end users into ambulatory surgical centers, hospitals, orthopedic clinics, home care, and others. Out of these segments, the hospital’s segment is projected to secure the highest share of the market by the end of 2033. This can be attributed to the fact that hospitals are better-equipped and have the right diagnostic and therapeutic devices available for the treatment of bone injuries and disorders. They also may or may not host a separate department or specialists for orthopedic cases. It was found that there were about 6,100 hospitals in the U.S. in 2022.
Our in-depth analysis of the bone growth stimulator market includes the following segments:
|
By Application |
|
|
By Product |
|
|
By End User |
|
North American Market Forecast
The North American bone growth stimulator market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033, backed by the increasing stances of road accidents, the growing prevalence of several bone disorders, coupled with the surge in the demand for osteoarthritis treatment, a massive surge in orthopedic procedures performed each year, and escalating healthcare expenditure in the region. Additionally, the growing number of older people in the population is giving rise to more cases of various chronic diseases in the region. For instance, nearly 31 million individuals have osteoarthritis in the United States.
Bioventus LLC acquired Misonix, Inc., which provides minimally invasive therapeutic ultrasound technologies and regenerative medicine.
Arthrex, Inc. has launched the industry's first FDA-cleared SwiveLoc ACL Repair Kit for the repairing of anterior cruciate ligament (ACL) tears.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?